Physician
Hurt, Jacknow, Moore, Connor, Wells, Michels, Yurco, Listrom & Huang
Hurt, Jacknow, Moore, Connor, Wells, Michels, Yurco, Listrom & Huang was paid $1.75M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 48% of everything it billed.
33Billing provider infoHURT, JACKNOW, MOORE, CONNOR, WELLS, MICHELS, YURCO, LISTROM & HUANG
AUSTIN, TX 78731
AUSTIN, TX 78731
33aNPI1255395810assigned 04/12/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.75M
24GClaims55,298
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Texas
Rank by total paid#6 of 97
Median peer was paid$24K
This provider vs. median74×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 206 | $594.40 | |
| 2019 | 110 | $519.12 | |
| 2020 | 5,096 | $121K | |
| 2021 | 13,768 | $430K | |
| 2022 | 12,081 | $428K | |
| 2023 | 11,796 | $449K | |
| 2024incomplete | 12,241 | $317K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 48% | 16,254 | 15,317 | $830K |
| 88307 | 28% | 8,516 | 8,200 | $493K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 7.0% | 6,049 | 5,952 | $123K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 4.7% | 3,308 | 3,248 | $82K |
| 85060 | 3.0% | 4,067 | 3,654 | $52K | |
| 86077 | 2.9% | 1,795 | 1,560 | $51K | |
| 88304 | 1.8% | 2,999 | 2,899 | $31K | |
| 88108 | 1.3% | 1,318 | 1,091 | $22K | |
| 88342 | <1% | 598 | 559 | $15K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 447 | 434 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 446 | 433 | $11K |
| 88141 | <1% | 500 | 491 | $8K |
40 more codes
| 88302 | <1% | 650 | $5K | |
| 88142 | <1% | 142 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 96 | $2K |
| 88312 | <1% | 79 | $2K | |
| 83020 | <1% | 194 | $1K | |
| 85027 | <1% | 965 | $914.46 | |
| 80053 | Comprehensive metabolic panel | <1% | 791 | $511.38 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,049 | $485.72 |
| 86850 | <1% | 502 | $433.11 | |
| 88189 | <1% | 24 | $413.55 | |
| 88164 | <1% | 44 | $367.19 | |
| 88300 | <1% | 83 | $316.78 | |
| 87340 | <1% | 191 | $210.37 | |
| 88313 | <1% | 12 | $183.79 | |
| 86900 | <1% | 777 | $142.03 | |
| 86901 | <1% | 771 | $142.03 | |
| 86762 | <1% | 126 | $134.02 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 93 | $101.92 |
| 86780 | <1% | 208 | $85.22 | |
| 81001 | <1% | 616 | $79.34 | |
| 88311 | <1% | 13 | $48.10 | |
| 87088 | <1% | 43 | $37.80 | |
| 85014 | <1% | 169 | $33.84 | |
| 85018 | <1% | 136 | $27.98 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 87 | $0.00 |
| 82947 | 0% | 76 | $0.00 | |
| 85007 | 0% | 24 | $0.00 | |
| 80179 | 0% | 16 | $0.00 | |
| 80143 | 0% | 16 | $0.00 | |
| 87467 | 0% | 131 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 179 | $0.00 |
| 84703 | 0% | 261 | $0.00 | |
| 83690 | 0% | 84 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 133 | $0.00 |
| 86880 | 0% | 72 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 69 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 18 | $0.00 |
| 84484 | 0% | 16 | $0.00 | |
| 82077 | 0% | 31 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGILLANI, MALIHA (CFO)
Parent organizationHURT, JACKNOW, MOORE, CONNOR, WELLS, MICHELS, YURCO, LISTROM & HUANG